SCHEMBL252095

SCHEMBL252095

Cn1nc(C(=O)O)c(=O)n(C)c1=O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.36
ADORA2A P29274 2/20 0.35
POLB P06746 2/20 0.34
ALDH1A1 P00352 2/20 0.34
PKM P14618 1/20 0.34
MAPT P10636 3/20 0.33
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ADORA2B P29275 2/20 0.33
HSD17B10 Q99714 1/20 0.33
ERCC1 P07992 1/20 0.33
FEN1 P39748 1/20 0.33
ERCC4 Q92889 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14877382 0.82 TP53 (0.41) TP53POLBALDH1A1PKMMAPT
SCHEMBL29524898 0.81 KMT2A (0.44) TP53L3MBTL1ADORA2APOLBALDH1A1
SCHEMBL22659694 0.78 NPSR1 (0.45) TP53L3MBTL1ADORA2APOLBALDH1A1
SCHEMBL14969113 0.76 MAPK1 (0.40) TP53ADORA2APOLBALDH1A1PKM
SCHEMBL15262543 0.75 TP53 (0.72) TP53POLBALDH1A1MAPTMEN1
SCHEMBL20503075 0.74 KDM4E (0.42) L3MBTL1ADORA2AALDH1A1LMNASMN1; SMN2
SCHEMBL248654 0.72 GSK3A (0.47) TP53L3MBTL1POLBALDH1A1PKM
SCHEMBL14969278 0.72 MET (0.38) TP53POLBALDH1A1PKMADORA2B
SCHEMBL16116321 0.72 ALDH1A1 (0.43) ADORA2AALDH1A1ADORA2B
SCHEMBL14969080 0.72 CFTR (0.39) TP53L3MBTL1ADORA2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4045036-B1 HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASES CHEMOCENTRYX INC (US) 2026-03-04 EP disclosed
US-12534450-B2 Methods and compositions for targeting PD-L1 ALIGOS THERAPEUTICS, INC. (US) 2026-01-27 US disclosed
US-12533354-B2 Triaryl compounds for treatment of PD-L1 diseases CHEMOCENTRYX, INC. (US) 2026-01-27 US disclosed
US-12497383-B2 Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases CHEMOCENTRYX, INC. (US) 2025-12-16 US disclosed
US-20240376078-A1 METHODS AND COMPOSITIONS FOR TARGETING PD-L1 ALIGOS THERAPEUTICS, INC. 2024-11-14 US disclosed
US-20230322731-A1 HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASES CHEMOCENTRYX, INC. 2023-10-12 US disclosed
US-11713307-B2 Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases CHEMOCENTRYX, INC. (US) 2023-08-01 US disclosed
US-20230044941-A1 TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES CHEMOCENTRYX, INC. 2023-02-09 US disclosed
US-20230044941-A1 TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES CHEMOCENTRYX, INC. 2023-02-09 US disclosed
US-20230031213-A1 METHODS AND COMPOSITIONS FOR TARGETING PD-L1 ALIGOS THERAPEUTICS, INC. 2023-02-02 US disclosed
US-10081608-B2 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides FMC CORPORATION (US) 2018-09-25 US disclosed
US-20170129861-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2017-05-11 US disclosed
US-9573909-B2 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides FMC CORPORATION (US) 2017-02-21 US disclosed
EP-3020709-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES FMC CORPORATION (US) 2016-05-18 EP disclosed
EP-2542538-B1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES FMC CORP (US) 2015-12-30 EP disclosed
US-20150203457-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2015-07-23 US disclosed
US-8969554-B2 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2015-03-03 US disclosed
US-20130102468-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2013-04-25 US disclosed
EP-2542538-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES Kumiai Chemical Industry Co., Ltd. (JP) 2013-01-09 EP disclosed
WO-2012002096-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12497383-B2 Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases CD274, PDCD1LG2, PDCD1 TP53 213/4885L3MBTL1 103/4885ADORA2A 269/4885
US-20230322731-A1 HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASES CD274, PDCD1LG2, PDCD1 TP53 213/4885L3MBTL1 103/4885ADORA2A 269/4885
US-10081608-B2 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides DDT, AADAC, DAZAP1 TP53 4244/4885L3MBTL1 1880/4885ADORA2A 1345/4885
US-20170129861-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES DDT, AADAC, DAZAP1 TP53 4244/4885L3MBTL1 1880/4885ADORA2A 1345/4885
US-11713307-B2 Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases CD274, PDCD1LG2, PDCD1 TP53 213/4885L3MBTL1 103/4885ADORA2A 269/4885
US-20150203457-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES DDT, AADAC, DAZAP1 TP53 4244/4885L3MBTL1 1880/4885ADORA2A 1345/4885
US-12533354-B2 Triaryl compounds for treatment of PD-L1 diseases CD274, PDCD1LG2, PDCD1 TP53 726/4885L3MBTL1 964/4885ADORA2A 1291/4885
US-12534450-B2 Methods and compositions for targeting PD-L1 CD274, PDCD1LG2, PDCD1 TP53 89/4885L3MBTL1 586/4885ADORA2A 2468/4885
US-20130102468-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES CBR3, DDT, CBR1 TP53 4291/4885L3MBTL1 2092/4885ADORA2A 980/4885
US-20230031213-A1 METHODS AND COMPOSITIONS FOR TARGETING PD-L1 CD274, PDCD1LG2, PDCD1 TP53 20/4885L3MBTL1 2195/4885ADORA2A 3665/4885
US-20230044941-A1 TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES CD274, PDCD1, PDCD1LG2 TP53 162/4885L3MBTL1 135/4885ADORA2A 229/4885
US-20240376078-A1 METHODS AND COMPOSITIONS FOR TARGETING PD-L1 CD274, PDCD1LG2, PDCD1 TP53 20/4885L3MBTL1 2195/4885ADORA2A 3665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.